阻止坏种子:HDAC3在缺血性中风后调节不同微质细胞的增殖
Yue Zhang1, Jiaying Li1, Yongfang Zhao1
1Department of Critical Care Medicine of Huashan Hospital, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai, China.
Science advances
|March 6, 2024
概括
在微质中抑制基因组脱乙酶3 (HDAC3) 通过减少有害炎症,改善缺血性中风后的结果. 这通过通过PU.1通路阻止促炎性微质细胞的增殖而发生.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 微质的两极分化和半阴影中的积累是脑神经炎症的关键,后缺血性中风,导致神经元损伤.
- 基斯脱乙酶3 (HDAC3) 调节炎症和细胞增殖,但其在中风后的微化和极化中的具体作用尚不清楚.
研究的目的:
- 研究HDAC3在微质极化中的作用及其对缺血性中风病理生理学的影响.
- 阐明HDAC3影响微质反应和中风结果的分子机制.
主要方法:
- 产生微质特异性HDAC3淘汰 (HDAC3-miKO) 的小鼠.
- 在中风后的微质上进行了RNA测序 (RNA-seq) 和ATAC测序 (ATAC-seq).
- 利用腺相关病毒 (AAV) 在微质中过度表达PU.1.
主要成果:
- 在缺血性中风后,HDAC3-miKO显著改善了长期功能和组织学结果.
- 微质中的HDAC3缺乏主要影响了线粒体过程,特别是抑制了促炎性微质的增殖.
- HDAC3-miKO改变了PU.1基因的染色质可访问性,PU.1过度表达逆转了HDAC3-miKO的保护作用.
结论:
- 在中风后,HDAC3/PU.1轴在调节微质增殖和极化方面发挥着至关重要的作用.
- 针对微质中的HDAC3提供了一种潜在的治疗策略,以减轻神经炎症并改善缺血性中风后的恢复.
相关概念视频
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...